Brief: Apollomics Announces Two New Cohorts In Global Phase 2 Sparta Study Of Vebreltinib In Non-Small Cell Lung Cancer And Other Solid Tumors With Met Dysregulation
31/10/2023 12:33
Oct 31 (Reuters) - Apollomics Inc APLM.O :
* APOLLOMICS ANNOUNCES TWO NEW COHORTS IN GLOBAL PHASE 2
SPARTA
STUDY OF VEBRELTINIB IN NON-SMALL CELL LUNG CANCER AND OTHER
SOLID TUMORS WITH MET DYSREGULATION
Source text for Eikon: ID:nGNX17mjrh
Further company coverage: APLM.O